Where results make sense

About us   |   Why use us?   |   Reviews   |   PR   |   Contact us

Multiple system atrophy - Wikipedia, the free encyclopedia MSA is associated with the degeneration of nerve cells in specific areas of the brain. Ongoing care from a neurologist specialized in "movement disorders" is recommended as the complex symptoms of MSA are often not familiar to less-specialized healthcare professionals. Olivopontocerebellar atrophy (OPCA) - characterized by progressive ataxia (an inability to coordinate voluntary muscular movements) of the gait and arms and dysarthria (difficulty in articulating words) (MSA - c, "c" = cerebellar dysfunction subtype.) en.wikipedia.org /wiki/Multiple_System_Atrophy   (724 words)

Geometry.Net - Health_Conditions: Multiple System Atrophy Multiple system atrophy (MSA) is a neurodegenerative disease marked by a combination of symptoms affecting movement, blood pressure, and other body functions; hence the label "multiple system" atrophy. When MSA begins with imbalance, incoordination, and difficulties in speaking (dysarthria), it is often called olivopontocerebellar atrophy; as the name suggests, this form of MSA is marked by degeneration in the cerebellum, a structure involved in balance and learned motor tasks. Multiple system atrophy Multiple System Atrophy is a neurological disorder that begins in adult life and is characterized by parkinsonism, cerebellar ataxia, and autonomic dysfunction in various combinations. www.geometry.net /detail/health_conditions/multiple_system_atrophy.html   (2823 words)

Multiple System Atrophy Multiple system atrophy is a rare neurological disorder characterized by a combination of parkinsonism, cerebellar and pyramidal signs, and autonomic dysfunction. Depletion of catecholaminergic neurons of the rostral ventrolateral medulla in multiple systems atrophy with autonomic failure. Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976-1990. www.dizziness-and-balance.com /disorders/central/movement/msa.html   (1093 words)

ataxias, neurosies, neurodegenerative diseases, multiple system atrophy, spino cerebellar ataxia Multiple system atrophy (MSA) is a rare neuro-degenerative disease marked by a combination of symptoms affecting movement, blood pressure, and other body functions; hence the label "multiple system" atrophy. Multisystem atrophy (MSA) is a progressive, sporadic disorder characterized by parkinsonism in association with varying degrees of cerebellar, pyramidal, intellectual, and autonomic dysfunction. Multiple system atrophy had to be divided into three categories: 1) striatonigral degeneration, which implies parkinsonism with some degree of cerebellar dysfunction; 2) olivopontocerebellar atrophy, which indicates primarily cerebellar defects with minor degrees of parkinsonism; and 3) the Shy-Drager syndrome, which reflects a predominance of autonomic failure. sky.prohosting.com /aletteke/ms-eh.html   (5355 words)

Multiple System Atrophy MSA often appears to be similar to Parkinson's Disease and/or other nuerological conditions such as Progressive Supranuclear Palsy and is often misdiagnosed. As the term "multiple system atrophy" implies, MSA can vary in its affect on the nervous system, resulting in a wide range of symptoms that may differ in various patients. MSA is generally separated into three main categories depending on the predominant symptoms. www.neurosy.org /disease/msa/msa.shtml   (1076 words)

MSA   (Site not responding. Last check: 2007-11-03) MSA typically presents in the fifth to seventh decade of life, with men predominating the condition by a factor of two to one. Multiple system atrophy is associated with both upper airway and central apnea, which can be life threatening. The majority of individuals diagnosed with MSA do not currently have a good prognosis with the survival rate typically being seven years from the time of diagnosis of the disease. www.ndrf.org /MSA.htm   (404 words)

Untitled Document Multiple system atrophy (MSA) refers to a group of progressive neurodegenerative disorders, previously referred to as Shy-Drager syndrome (SDS) or striatonigral degeneration (SND), now categorized as MSA-P (P indicates that parkinsonism is the most prominent feature) and olivoponto­cerebellar atrophy, categorized as MSA-C (C indicates that cerebellar dysfunction manifested by incoordination (ataxia). Disturbance of the autonomic nervous system (dysautonomia) causing lightheadedness or fainting spells upon standing (because of a marked fall in blood pressure), incontinence of bowel and bladder, and impotence in males, differentiates MSA from PD. MSA patients also frequently snore during sleep and have longer than normal pauses in breathing during sleep, known as sleep apnea, and combative behavior during sleep, known as REM Behavioral Disorder (RBD). www.bcm.edu /neurol/jankovic/educ_msa.htm   (1089 words)

multiple system atrophy   (Site not responding. Last check: 2007-11-03) Multiple system atrophy is a rare neurological disorder characterized by a combination... Multiple system atrophy is a neurological disorder that begins in... Multiple system atrophy (MSA) is a disorder in which multiple parts of the nervous system... www.search-e.com /find/multiple+system+atrophy.shtml   (328 words)

Multisystem Atrophy - Overview, Incidence, & Anatomy - neurologychannel Multisystem atrophy (MSA) is a group of rare, multisystem degenerative diseases that have several clinical features of Parkinson's disease and are sometimes referred to as the "Parkinsonism-plus syndromes." When MSA was first identified in 1960, it was named "Shy-Drager Syndrome" after the two physicians who first described its symptoms. The underlying neurological anatomy of MSA is similar to that of Parkinson's disease, but with some noticeable and important differences. www.neurologychannel.com /msa   (391 words)

The Parkinson's Institute Movement Disorders As the term "multiple system atrophy" implies, MSA can vary in its affect on the nervous system, resulting in a range of symptoms. Shy-Drager syndrome is the term used to describe the MSA variant manifesting a as profound impairment of "autonomic" function as well as parkinsonism. Olivopontocerebellar atrophy, is the term applied to the MSA variant manifesting prominent "ataxia."along with parkinsonism. www.parkinsonsinstitute.org /movement_disorders/multiple_system.html   (348 words)

Response of the Parkinsonian Symptoms of Multiple System Atrophy to ECT -- HOOTEN et al. 155 (11): 1626 -- American ...   (Site not responding. Last check: 2007-11-03) Response of the Parkinsonian Symptoms of Multiple System Atrophy to ECT -- HOOTEN et al. Response of the Parkinsonian Symptoms of Multiple System Atrophy to ECT system atrophy are poorly responsive to levodopa therapy (2), ajp.psychiatryonline.org /cgi/content/full/155/11/1626d   (493 words)

Multiple System Atrophy Information Page: National Institute of Neurological Disorders and Stroke (NINDS) Multiple system atrophy (MSA) refers to three slowly progressive related disorders that affect the central and autonomic nervous systems. MSA is twice as common in men as in women. MSA is a progressive disorder and most patients have a life expectancy after diagnosis of about 10 years or less. www.ninds.nih.gov /disorders/msa/msa.htm   (517 words)

Multiple System Atrophy with Orthostatic Hypotension Information Page: National Institute of Neurological Disorders and ... Multiple system atrophy with orthostatic hypotension is the current classification for a neurological disorder that was once called Shy-Drager syndrome. A progressive disorder of the central and autonomic nervous systems, it is characterized by orthostatic hypotension (an excessive drop in blood pressure when standing up) which causes dizziness or fainting. Multiple system atrophy can occur without orthostatic hypotension, but it is rare. accessible.ninds.nih.gov /disorders/msa_orthostatic_hypotension/msa_orthostatic_hypotension.htm   (497 words)

Multiple System Atrophy (MSA) treatment at Mayo Clinic. Multiple system atrophy (MSA), one of several Parkinson's plus syndromes, is a rare disorder, although specialists at Mayo Clinic evaluate about 400 MSA patients each year. Patients with multiple system atrophy eventually develop symptoms of both Parkinson's disease (slowed movement, rigidity) and autonomic dysfunction (problems with blood pressure, heart rate, digestion, sexual function, etc.), but patients often develop one set of symptoms before the other, making diagnosis difficult. Multiple system atrophy is a progressive, adult-onset disorder which affects many areas of the brain and the associated systems in the body. www.mayoclinic.org /multiplesystematrophy-jax/index.html   (294 words)

MSA FAQ Multiple system atrophy (MSA) is a rare neurodegenerative disease marked by a combination of symptoms affecting movement, blood pressure, and other body functions; hence the label "multiple system" atrophy. MSA can manifest in a variety of different ways and progresses in an unpredictable sequence and time scale for each patient. MSA may be difficult to diagnose in the early stages because it can take years for key symptoms to develop. www.shy-drager.org /msa_faq.htm   (4800 words)

eMedicine - Multiple System Atrophy : Article by André Diedrich, MD, PhD   (Site not responding. Last check: 2007-11-03) MSA is classified as possible, probable, or definite on the basis of its features and on criteria in 3 clinical domains: autonomic and/or urinary dysfunction, parkinsonism, and cerebellar dysfunction (Table 2, Table 3, Table 4, Table 5, Table 6). MSA is suggested when (1) disability progresses rapidly, (2) patients are poorly responsive to levodopa, (3) autonomic features such as urinary retention or incontinence or orthostatic hypotension are pronounced, and (4) rigidity and bradykinesia are out of proportion to tremor. MSA is a difficult diagnosis, especially early in the clinical course, and the initial physician often misdiagnoses the condition. www.emedicine.com /neuro/topic671.htm   (7112 words)

Autonomic Disorders Research and Treatment Program - Department of Neurology - Mount Sinai School of Medicine Multiple system atrophy is a neurological disorder that begins in adult life and is characterized by parkinsonism, cerebellar ataxia, and autonomic dysfunction in various combinations. Multiple system atrophy shares many of the signs and symptoms of Parkinson’s disease. Thus, it is not surprising that multiple mystem mtrophy is frequently misdiagnosed as Parkinson’s disease. www.mssm.edu /neurology/autodis/disorders/msa   (235 words)

Session P79.2   (Site not responding. Last check: 2007-11-03) Patients with multiple system atrophy are known to have autonomic dysfunction and to be at higher risk of adverse outcome, included sudden death. In a prospective study, we evaluated the hypothesis that QT variability is abnormal in multiple system atrophy. Time and frequency domain QTV was assessed from 24-hour Holter monitoring in 7 consecutive multiple system atrophy patients, 4 females and 3 males, mean age 66±12 years and in 7 healthy subjects, 4 females and 3 males, mean age 54±11 years. www.cinc.org /Program/p79-2.htm   (291 words)

Multiple System Atrophy Synonyms, Eastern North Carolina, NC Multiple system atrophy (MSA) is a rare progressive neurological disorder characterized by a varying combination of symptoms. The exact cause of multiple system atrophy is unknown. Additionally, there is a hereditary form of olivopontocerebellar atrophy that is not part of the multiple system atrophy spectrum. www.uhseast.com /113579.cfm   (438 words)

REM sleep behaviour disorder differentiates pure autonomic failure from multiple system atrophy with autonomic failure ... Primary autonomic failure syndromes comprise pure autonomic failure and multiple system atrophy with autonomic failure. On the contrary, the pathology of multiple system atrophy is characterised by widespread involvement of the peripheral, jnnp.bmjjournals.com /cgi/content/full/64/5/683   (1895 words)

Multiple system atrophy Multiple system atrophy (MSA) with postural hypotension, also called Shy-Drager syndrome, is a progressive disorder of the central and sympathetic nervous systems. MSA has been classified clinically into three types, olivopontocerebellar atrophy (OPCA), which primarily affects balance, coordination, and speech; a parkinsonian form (striatonigral degeneration), which can resemble Parkinson's disease because of slow movement and stiff muscles; and a mixed cerebellar and parkinsonian form. Argyrophilic intracytoplasmic inclusions in oligodendrocytes (AGCIs) are widespread, not only in the olivopontocerebellar and striatonigral systems but also among fibers connecting their affecting lesions of MSA. perso.wanadoo.fr /adna/MSA.html   (399 words)

Multiple system atrophy However, in MSA there is more widespread neurologic damage and damage to the autonomic nervous system (the portion of the nervous system that controls involuntary functions). There is progressive degeneration of the nervous system, with damage to all parts of the nervous system, including the brain. MSA develops gradually and is most often diagnosed in men older than 60. www.umm.edu /ency/article/000757.htm   (288 words)

First mouse model for multiple system atrophy points to new treatment targets for brain diseases MSA is so named because it affects multiple parts of the nervous system. Initially MSA was given three names, based on the symptoms physicians had observed. Collectively, MSA now includes three related disorders characterized by their most prominent symptoms: olivopontocerebellar atrophy, which affects balance, coordination, and speech; striatonigral degeneration, the closest to Parkinson's disease because of slow movement and stiff muscles; and Shy-Drager syndrome, which involves altered bowel, bladder, and blood-pressure control. www.eurekalert.org /pub_releases/2005-03/uopm-fmm031705.php   (615 words)

Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD -- Schocke et al. 58 ... Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD -- Schocke et al. Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD Differentiating multiple system atrophy from Parkinson's disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging www.neurology.org /cgi/content/abstract/58/4/575   (570 words)

Multi System Atrophy and My Story, Multiple System Atrophy, Multisystem Atrophy Multi System Atrophy and My Story was designed to provide a better understanding of this rare disorder. Everyday someone asks me what Multi System Atrophy (or MSA or Multiple System Atrophy) is and it's hard to explain. The Beginning A wonderful ongoing story by a dear friend about her fight with PD and her friend's battle with MSA. frontpage.tripod.com /msainfo   (384 words)

Multiple System Atrophy Multiple system atrophy is a generic term used to describe a group of degenerative disorders of the brain that variably affect parts of the brain controlling coordination, movement, and so called autonomic functions--- those involving regulation of blood pressure, digestion/urination/defacation, sweating etc.--- so called visceral functions. The disease typically first presents with symptoms of damage to one of these systems, but ultimately progresses to affect the others as well over time. Unfortunately, the disease is typically terminal and generally untreatable, although different medications may be tried to give symptomatic relief from individual problems/symptoms related to malfunctioning of each of the affected symptoms. www.medhelp.org /forums/neuro/archive/242.html   (325 words)

Try your search on: Qwika (all wikis)

About us   |   Why use us?   |   Reviews   |   Press   |   Contact us   Copyright © 2005-2007 www.factbites.com Usage implies agreement with terms.